Fragment hopping-based discovery of novel sulfinylacetamide-diarylpyrimidines (DAPYs) as HIV-1 nonnucleoside reverse transcriptase inhibitors

Sheng Han; Ya-Li Sang; Yan Wu; Yuan Tao; Christophe Pannecouque; De Clercq Erik; Chunlin Zhuang; Fen‐Er Chen

doi:10.1016/j.ejmech.2019.111874

Back

Fragment hopping-based discovery of novel sulfinylacetamide-diarylpyrimidines (DAPYs) as HIV-1 nonnucleoside reverse transcriptase inhibitors

Article 2019 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2019

Fragment-based discovery of sulfur-containing diarylbenzopyrimidines as novel nonnucleoside reverse transcriptase inhibitors

Sheng Han, Yuan Lei, Christophe Pannecouque, De Clercq Erik, Chunlin Zhuang, Fen‐Er Chen

Article2023

Discovery of diarylpyrimidine derivatives bearing piperazine sulfonyl as potent HIV-1 nonnucleoside reverse transcriptase inhibitors

Xiangyi Jiang, Boshi Huang, Shawn Rumrill, David Pople, Waleed A. Zalloum, Dongwei Kang, Fabao Zhao, Xiangkai Ji, Zhen Gao, Lide Hu, Zhao Wang, Minghui Xie, De Clercq Erik, Francesc X. Ruiz, Eddy Arnold, Christophe Pannecouque, Xinyong Liu, Peng Zhan

Article2020

Scaffold Hopping in Discovery of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: From CH(CN)-DABOs to CH(CN)-DAPYs

Tingting Li, Christophe Pannecouque, De Clercq Erik, Chunlin Zhuang, Fen‐Er Chen

Article2019

Follow on-based optimization of the biphenyl-DAPYs as HIV-1 nonnucleoside reverse transcriptase inhibitors against the wild-type and mutant strains

Ya-Li Sang, Sheng Han, Shuwen Han, Christophe Pannecouque, De Clercq Erik, Chunlin Zhuang, Fen‐Er Chen

Article2010

Lead Optimization of Diarylpyrimidines as Non‐nucleoside Inhibitors of HIV‐1 Reverse Transcriptase

Zhao‐Sen Zeng, Yonghong Liang, Xiaoqing Feng, Fen‐Er Chen, Christophe Pannecouque, Jan Balzarini, De Clercq Erik